Drug Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Drug Development stocks.

Drug Development Stocks Recent News

Date Stock Title
May 9 MNMD Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript
May 8 ONCT Oncternal Therapeutics Q1 2024 Earnings Preview
May 8 MNMD Mind Medicine GAAP EPS of -$1.14 misses by $0.60
May 8 MNMD MindMed Reports First Quarter 2024 Financial Results and Business Updates
May 8 ITCI Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
May 8 CERT Q1 2024 Certara Inc Earnings Call
May 8 LDOS Leidos (LDOS) is a Great Momentum Stock: Should You Buy?
May 8 ITCI Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
May 8 BLTE Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 8 LDOS 3 Momentum Anomaly Stocks to Bet on as Markets Move Northward
May 8 SWTX SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
May 8 CERT Certara Inc (CERT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
May 8 CERT Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript
May 8 ITCI Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
May 7 CERT Certara, Inc. (CERT) Q1 Earnings Meet Estimates
May 7 CERT Certara Non-GAAP EPS of $0.10 in-line, revenue of $96.7M beats by $3.07M
May 7 CERT Certara Inc (CERT) Q1 2024 Earnings: Mixed Results Amidst Revenue Growth and Net Loss
May 7 MNMD Mind Medicine Q1 2024 Earnings Preview
May 7 CERT Certara Reports First Quarter 2024 Financial Results
May 7 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q1 2024 Earnings Call Transcript
Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Browse All Tags